Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse: British Journal of Haematology

V. Montefusco, A. Corso, M. Galli, I. Ardoino, S. Pezzatti, C. Carniti, F. Patriarca, F. Gherlinzoni, R. Zambello, S. Sammassimo, M. Marcatti, A. Nozza, C. Crippa, A.M. Cafro, L. Baldini, P. Corradini

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse: British Journal of Haematology'. Together they form a unique fingerprint.

Medicine & Life Sciences